PP01.81 REZILIENT2: Phase 2 Study of Zipalertinib in Patients with Advanced NSCLC with Exon 20 Insertions and Other Uncommon EGFR Mutations
Journal of Thoracic Oncology(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Thoracic Oncology(2024)